The value of chronic opioid therapy (COT) for chronic non-cancer pain (CNCP) patients is determined by a balance of poorly understood benefits and harms. Traditionally, this balance has been framed as the potential for improved pain control versus risks of iatrogenic addiction, drug diversion, and aberrant drug-related behaviors. These potential harms are typically defined from the providers' perspective. This paper seeks to clarify difficulties with the long-term use of opioids for CNCP from the patients' perspective. We used the Prescribed Opioids Difficulties Scale (PODS) to assess current problems and concerns attributed to opioid use by 1144 adults receiving COT. Subjects were grouped into low (56.9%), medium (25.6%) and high (17.5%) PODS scorers. Among patients with high PODS scores, 64% were clinically depressed and 78% experienced high levels of pain-related interference with activities, compared to 28% depressed and 60% with high interference with activities among those with low PODS scores. High levels of opioid-related problems and concerns were not explained by differences in pain intensity or persistence. Patients with medium to high PODS scores were often concerned about their ability to control their use of opioid medications, but prior substance abuse diagnoses and receiving excess days supply of opioids were much less common in these patients than depression and pain-related interference with activities. These results suggest two types of potential harm from COT attributed by CNCP patients to opioids: psychosocial problems that are distinct from poor pain control and opioid control concerns that are distinct from opioid misuse or addiction. Ó
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Introduction
Long-term use of opioids for chronic non-cancer pain (CNCP) has increased dramatically in the past two decades [5, 17] . The overall value of chronic opioid therapy (COT) for patients with CNCP is determined by a complex balance of benefits and harms that is not well understood. This balance has been framed in guidelines as the potential for sustained pain relief for patients suffering from CNCP versus the potential of iatrogenic or recurrent addiction, or drug diversion for non-medical use [1, 15] . A recent consensus panel recommended that this pain relief be evaluated in at least two of four core outcome domains: (1) Pain intensity, (2) physical functioning, (3) emotional functioning, and (4) participant ratings of overall improvement [9] . The potential harms of COT have recently been broadened beyond addiction and diversion to include aberrant drug-related behaviors, which encompass various forms of abuse and misuse of prescription opioids (e.g., forging prescriptions, going to multiple doctors to obtain opioids) as well as behaviors potentially indicative of poor pain control and ''pseudo-addiction" (e.g., raising opioid dose on one's own, patient concerns that opioid use might lead to addiction) [7, 13, 19] .
Beyond opioid misuse and abuse, there is a broader spectrum of psychosocial difficulties potentially associated with COT that may be of concern to patients, e.g., disturbances of mood and cognition or reduced activity levels. Because these kinds of psychosocial difficulties may be caused by chronic pain or by opioid medications used to treat chronic pain, it is difficult to establish causation for such difficulties. However, an important first step is to understand the perspectives of patients receiving COT regarding the kinds of difficulties they attribute to opioid use. Research to date on the potential harms of COT has largely focused on harms perceived by clinicians such as aberrant behaviors and abuse. However, patients may perceive difficulties with COT that differ from the concerns of their clinicians. Furthermore, patients' experiences with COT are central to the ongoing debate about the benefits and risks of chronic opioid therapy for CNCP.
